PAIN (Pain AI iNtervention) Platform for Patients at Home

Overview

About this study

The purpose of this study is to personalize pain medication regimens leveraging sensor-driven, digital ecosystems that can recognize subtle markers of pain and over-medication. Multiple sensors will be used to measure the autonomic features of pain and overdose and thereby build a composite and objective profile to determine pain needs and indicators of safety.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients 18 years or older.
Patients undergoing low-risk outpatient plastic surgery and orthopedic procedures with expected pain intensities ranging from mild to severe.

Exclusion Criteria:

Patients with severe allergies (e.g., blistering) to medical glue used in the ECG leads that will hold the device in place.
Patients with barriers to effective communication.
Patients incapable of taking oral medication.
Patients receiving a nerve catheter for pain control after surgery (e.g., patients undergoing carpometacarpal arthroplasty).
Patients who have been taking medical therapy for chronic pain for 6 months or more.
Patients with a previous diagnosis of severe anxiety disorders (e.g., post-traumatic stress disorder).
Patients who are immobile at baseline.
Pregnant women.

Eligibility last updated 5/25/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Antonio Forte, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Mauricia Buchanan R.N. Buchanan.Mauricia@mayo.edu

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Antonio Forte, M.D., Ph.D.

Closed-enrolling by invitation

Contact information:

Mauricia Buchanan R.N.

Buchanan.Mauricia@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials